RCEL
Avita Medical Inc.
$3.87
+$0.20(+5.45%)
29
Overall
40
Value
18
Tech
--
Quality
Market Cap
$97.43M
Volume
378.73K
52W Range
$3.60 - $14.16
Target Price
$7.50
Order:
Income Statement
| Metric | Trend | Chart | 2020 Jun | 2021 Jun | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $14.3M | $29.2M | $34.4M | $50.1M | $64.3M | ||
| Total Revenue | $14.3M | $29.2M | $34.4M | $50.1M | $64.3M | ||
| COST OF GOODS SOLD | |||||||
| Cost of Revenue | $3.0M | $5.9M | $6.0M | $7.8M | $9.1M | ||
| GROSS PROFIT | |||||||
| Gross Profit | $11.3M | $23.3M | $28.4M | $42.4M | $55.2M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $57.9M | $51.9M | $55.9M | $86.4M | $111.8M | ||
| Research & Development | $9.2M | $14.8M | $13.9M | $20.8M | $20.4M | ||
| Research Expense | $9.2M | $14.8M | $13.9M | $20.8M | $20.4M | ||
| Selling, General & Administrative | $48.7M | $37.1M | $45.2M | $65.6M | $91.4M | ||
| Selling & Marketing Expenses | $15.7M | $14.7M | $21.9M | $37.3M | $58.2M | ||
| General & Administrative Expenses | $33.0M | $22.4M | $23.3M | $28.3M | $33.2M | ||
| Promotion & Advertising | $51.0K | $73.0K | $216.0K | -- | -- | ||
| Salaries & Wages | $16.5M | $5.7M | $7.0M | -- | -- | ||
| Depreciation & Amortization | $346.0K | $606.0K | $510.0K | $597.0K | $1.0M | ||
| Depreciation & Amortization | $3.0M | $5.9M | $510.0K | -- | -- | ||
| Amortization | $364.0K | $601.0K | $803.0K | $828.0K | $5.6M | ||
| Other Operating Expenses | $-3.9M | $-2.1M | $-3.2M | $-1.4M | $111.8M | ||
| OPERATING INCOME | |||||||
| Operating income | $-42.7M | $-26.5M | $-27.5M | $-42.7M | $-56.6M | ||
| EBITDA | $-41.5M | $-25.8M | $-26.0M | $-33.5M | $-55.3M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $33.0K | $22.0K | $16.0K | $1.1M | $5.4M | ||
| Net Non-Operating Interest Income/Expense | $-33.0K | $-22.0K | $-16.0K | $-1.1M | $-5.4M | ||
| Other Income/Expense | $-686.0K | $-17.0K | $892.0K | $-8.5M | $-163.0K | ||
| Other Special Charges | $686.0K | $17.0K | $892.0K | $8.5M | $163.0K | ||
| SPECIAL ITEMS | |||||||
| Special Income Charges | $3.9M | -- | -- | -- | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-42.0M | $-26.5M | $-26.6M | $-34.2M | $-56.4M | ||
| Pre-Tax Income | $-42.0M | $-26.5M | $-26.6M | $-35.3M | $-61.8M | ||
| INCOME TAX | |||||||
| Tax Provision | $4.0K | $38.0K | $36.0K | $66.0K | $54.0K | ||
| NET INCOME | |||||||
| Net Income | $-42.0M | $-26.6M | $-26.7M | $-35.4M | $-61.8M | ||
| Net Income (Continuing Operations) | $-42.0M | $-26.6M | $-26.7M | $-35.4M | $-61.8M | ||
| Net Income (Discontinued Operations) | $-42.0M | $-26.6M | $-26.7M | $-35.4M | $-61.8M | ||
| Net Income (Common Stockholders) | $-42.0M | $-26.6M | $-26.7M | $-35.4M | $-61.8M | ||
| TOTALS | |||||||
| Total Expenses | $60.9M | $57.8M | $61.9M | $94.2M | $120.8M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $20.3M | $22.7M | $25.0M | $25.3M | $25.9M | ||
| Average Shares Outstanding (Diluted) | $20.3M | $22.7M | $25.0M | $25.3M | $25.9M | ||
| Shares Outstanding | $21.5M | $24.9M | $25.3M | $25.7M | $26.4M | ||
| Basic EPS | $-2.07 | $-1.17 | $-1.07 | $-27.93 | $-2.39 | ||
| Basic EPS (Continuing Operations) | $-2.07 | $-1.17 | $-1.07 | $-1.4 | $-2.39 | ||
| Diluted EPS | $-2.07 | $-1.17 | $-1.07 | $-27.93 | $-2.39 | ||
| Diluted EPS (Continuing Operations) | $-2.07 | $-1.17 | $-1.07 | $-1.4 | $-2.39 | ||
| OTHER METRICS | |||||||
| Acquisition Expense | -- | -- | $6.0M | -- | -- | ||
| Depletion | $3.0M | $5.9M | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | $-3.0K | -- | -- | ||
| Other Gand A | $33.0M | $22.4M | $23.3M | $28.3M | $33.2M | ||
| Other Write Off | $43.0K | -- | $9.0K | -- | -- | ||
| Selling Expense | $3.0M | -- | $6.0M | -- | -- | ||
| Othspecchg | $-3.9M | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RCEL | $3.87 | +5.4% | 378.73K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |